Zivaclav-625
ZIVACLAV-625
(Amoxicillin 500 mg + Potassium Clavulanate 125 mg Tablets)
Overview
ZIVACLAV-625 is a broad-spectrum antibiotic combination of Amoxicillin and Potassium Clavulanate, formulated to provide effective treatment for moderate to severe infections caused by resistant bacteria. The synergy of Amoxicillin (a powerful penicillin-class antibiotic) and Clavulanate (a beta-lactamase inhibitor) makes this combination an ideal choice against infections that are difficult to treat.
This dual-action formula is strong enough to tackle light resistance and ensures reliable outcomes in respiratory, urinary, skin, soft tissue, gynecological, and dental infections.
Key Ingredients & Their Benefits
Amoxicillin (500 mg):
Broad-spectrum antibiotic effective against both gram-positive and gram-negative bacteria.
Rapid absorption with peak serum levels in 1–2 hours.
Safe, effective, and well-tolerated antibiotic with proven efficacy.
Clavulanate Potassium (125 mg):
Irreversibly inhibits beta-lactamases, enzymes that make bacteria resistant to antibiotics.
Extends and enhances the antibacterial activity of Amoxicillin.
Prevents degradation of Amoxicillin, making treatment more effective against resistant organisms.
Clinical Benefits
✔ Effective in treating resistant bacterial infections.
✔ Provides broad-spectrum coverage across multiple organ systems.
✔ Rapid onset of action with sustained efficacy.
✔ Well tolerated with a favorable safety profile.
✔ Reduces recurrence of infections by eliminating resistant strains.
Therapeutic Indications (Used In):
LRTI & UTI Infections (Lower Respiratory Tract & Urinary Tract Infections)
Skin & Soft Tissue Infections
Bone & Joint Infections
Gynecological Infections
Surgical Prophylaxis (to prevent post-operative infections)
Otitis Media & Dental Infections
Recurrent Tonsillitis, Sinusitis & Bronchitis
Why ZIVACLAV-625?
Potent combination that excels against infections.
Protects against beta-lactamase producing bacteria.
Trusted solution for moderate to severe infections.
Ensures better clinical outcomes and faster recovery.
👉 “Strong Enough to Tackle Resistance – ZIVACLAV-625: Combination That Excels Against Infections.”
